0001567619-19-008334.txt : 20190403
0001567619-19-008334.hdr.sgml : 20190403
20190403171353
ACCESSION NUMBER: 0001567619-19-008334
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190401
FILED AS OF DATE: 20190403
DATE AS OF CHANGE: 20190403
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KIRK RANDAL J
CENTRAL INDEX KEY: 0001091823
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-12584
FILM NUMBER: 19729989
MAIL ADDRESS:
STREET 1: 1881 GROVE AVENUE
CITY: RADFORD
STATE: VA
ZIP: 24141
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: INTREXON CORP
CENTRAL INDEX KEY: 0001356090
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
STATE OF INCORPORATION: VA
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-12584
FILM NUMBER: 19729990
BUSINESS ADDRESS:
STREET 1: 1750 KRAFT DRIVE
STREET 2: SUITE 1400
CITY: BLACKSBURG
STATE: VA
ZIP: 24060
BUSINESS PHONE: 301-556-9809
MAIL ADDRESS:
STREET 1: 1750 KRAFT DRIVE
STREET 2: SUITE 1400
CITY: BLACKSBURG
STATE: VA
ZIP: 24060
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Synthetic Biologics, Inc.
CENTRAL INDEX KEY: 0000894158
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133808303
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9605 MEDICAL CENTER DRIVE
STREET 2: SUITE 270
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
BUSINESS PHONE: (734) 332-7800
MAIL ADDRESS:
STREET 1: 9605 MEDICAL CENTER DRIVE
STREET 2: SUITE 270
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
FORMER COMPANY:
FORMER CONFORMED NAME: ADEONA PHARMACEUTICALS, INC.
DATE OF NAME CHANGE: 20081027
FORMER COMPANY:
FORMER CONFORMED NAME: PIPEX PHARMACEUTICALS, INC.
DATE OF NAME CHANGE: 20061214
FORMER COMPANY:
FORMER CONFORMED NAME: SHEFFIELD PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19970730
4
1
doc1.xml
FORM 4
X0306
4
2019-04-01
1
0000894158
Synthetic Biologics, Inc.
SYN
0001091823
KIRK RANDAL J
C/O THIRD SECURITY, LLC
1881 GROVE AVENUE
RADFORD
VA
24141
0
0
1
0
0001356090
INTREXON CORP
C/O LEGAL DEPARTMENT
20374 SENECA MEADOWS PARKWAY
GERMANTOWN
MD
20876
0
0
1
0
Common Stock
2019-04-01
4
S
0
11413
0.67
D
92159
I
by NRM VII Holdings
Common Stock
2019-04-01
4
S
0
30265
0.67
D
244402
I
by Intrexon
Common Stock
2019-04-02
4
S
0
3737
0.66
D
88422
I
by NRM VII Holdings
Common Stock
2019-04-02
4
S
0
9909
0.66
D
234493
I
by Intrexon
Common Stock
2019-04-03
4
S
0
26080
0.65
D
62342
I
by NRM VII Holdings
Common Stock
2019-04-03
4
S
0
69161
0.65
D
165332
I
by Intrexon
Pursuant to a joint selling program, NRM VII Holdings I, LLC ("NRM VII Holdings") and Intrexon Corporation ("Intrexon") sold shares on a pro rata basis.
The indicated share amount is reflective of a 1:35 reverse stock split effected by the issuer on August 10, 2018.
Randal J. Kirk controls NRM VII Holdings. Shares held by this entity may be deemed to be indirectly beneficially owned (as defined under Rule 13d- 3 promulgated under the Securities Exchange Act of 1934, as amended) by Mr. Kirk. Mr. Kirk disclaims beneficial ownership of such shares, except to the extent of any pecuniary interest therein.
Randal J. Kirk, directly and through certain affiliates, is the largest shareholder of Intrexon and serves as Intrexon's Chairman of the Board and Chief Executive Officer. Mr. Kirk may therefore be deemed to have voting and dispositive power over the shares of the issuer owned by Intrexon. Shares held by Intrexon may be deemed to be indirectly beneficially owned (as defined under Rule 13d-3 promulgated under the Securities Exchange Act of 1934, as amended) by Mr. Kirk. Mr. Kirk disclaims beneficial ownership of such shares, except to the extent of any pecuniary interest therein.
/s/ Randal J. Kirk
2019-04-03
/s/ Randal J. Kirk, CEO of Intrexon Corporation
2019-04-03